LC-MS/MS Method for Simultaneous Quantification of the First-Line Anti-Tuberculosis Drugs and Six Primary Metabolites in Patient Plasma: Implications for Therapeutic Drug Monitoring

LC-MS/MS Method for Simultaneous Quantification of the First-Line Anti-Tuberculosis Drugs and Six Primary Metabolites in Patient Plasma: Implications for Therapeutic Drug Monitoring

Posted by Adam Awdish on

Single Donor Human Plasma (Blood Derived) from Innovative Research was used in the following study:

 

LC-MS/MS Method for Simultaneous Quantification of the First-Line Anti-Tuberculosis Drugs and Six Primary Metabolites in Patient Plasma: Implications for Therapeutic Drug Monitoring

Agnija Kivrane, Solveiga Grinberga, Eduards Sevostjanovs, Viktorija Igumnova, Ilva Pole, Anda Viksna, Dace Bandere, Alvils Krams, Andra Cirule, Osvalds Pugovics, Renate Ranka

Journal of Chromatography B
November 15, 2021

Tuberculosis (TB) is an infection caused by an airborne bacteria called Mycobacterium tuberculosis. Despite the advances in treating TB over the years there is still an estimated 10 million new cases around the world annually, and roughly 15% of these patients experience a drug resistant form of the disease or will relapse into infection following normal treatment.

Pharmacokinetic profiling of drugs and their metabolites via observation in the biological matrix is one of the best tools available for gathering information regarding treatment efficacy. In this study, researchers developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring common TB drugs and their metabolites in human plasma.

 

Related products available from Innovative Research also include:

Pooled Human Serum Off The Clot

Single Donor Human Whole Blood

Pooled Human Plasma Apheresis Derived

  • Tags: Human Plasma, Pooled Human Plasma (Blood Derived), Single Donor Human Plasma Whole Blood Derived

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    We have biological products and research materials to assist with early phase next gen COVID vaccine research
    This autumn, as clinical trials get underway to evaluate the effectiveness of the most ...
    Read the Article
    Monoclonal Antibody to VLDLR (MA-1H10): An Explainer
    The Innovative Research lab pulled together an explainer on one of our recently popular...
    Read the Article
    Update Post: A Timeline of Hemophilia Research
    Hemophilia is a bleeding disorder in which the body is unable to form blood clots prope...
    Read the Article

    ← Older Post Newer Post →

    ×